« Previous Article
Next Article »

Original Research

Online Publishing Date:
21 / 02 / 2022

 


Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study

Kamalakar Vasant Gajare, Vijay Ukhalkar, Suresh Podhade, Santosh Pathak, Sasibhushan Vedula, Rajiva Kumar Rai, Sastry JLN.


Abstract
Background: The pathogenesis and treatment of Ashmari (Urolithiasis) are well explained in Ayurveda texts. While various herbal remedies are used for the medical management of Urolithiasis, very few have been studied clinically for safety and efficacy.

Objective: To evaluate the safety and efficacy of Stondab tablet in reducing the size and expelling of urinary calculi and in relieving the symptoms of calculi.

Materials and Methods: The study was conducted in a Randomized, Active Controlled, Open Labelled, Multi-centric design with 108 subjects completing the study. Subjects were given either test product or comparator as per randomization, two tablets, thrice daily for the period of 90 days to be taken with water. Subjects were followed up every 15 days for 90 days for clinical and laboratory assessment as planned.

Results: Subjects in the Stondab group showed an expulsion rate of calculi (5-12 mm) of 49.23% and 66.66% (less than 5 mm) at the end of 90 days. There was a reduction in clinical symptoms like pain in the abdomen, burning micturition, hematuria, painful micturition, frequency of micturition, and the number of episodes of pain in the Stondab group and which was comparable with the comparator group. The study product was found to be safe and well-tolerated.

Conclusion: It may be concluded that Stondab is safe and effective in the management of renal calculi. It also helped in the reduction of clinical symptoms of renal calculi as well as there is a clinically significant effect on new stone formation.

Key words: Abdominal pain, Expulsion rate, Renal Calculi, Stondab, Urolithiasis.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Kamalakar Vasant Gajare
Articles by Vijay Ukhalkar
Articles by Suresh Podhade
Articles by Santosh Pathak
Articles by Sasibhushan Vedula
Articles by Rajiva Kumar Rai
Articles by Sastry JLN
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Gajare KV, Ukhalkar V, Podhade S, Pathak S, Vedula S, Rai RK, JLN S. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. J. res. tradit. med. 2022; 8(1, Jan- June 2022): 3-12. doi:10.5455/jrtm.2022/125819


Web Style

Gajare KV, Ukhalkar V, Podhade S, Pathak S, Vedula S, Rai RK, JLN S. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. https://www.tmjournal.org/?mno=125819 [Access: June 08, 2024]. doi:10.5455/jrtm.2022/125819


AMA (American Medical Association) Style

Gajare KV, Ukhalkar V, Podhade S, Pathak S, Vedula S, Rai RK, JLN S. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. J. res. tradit. med. 2022; 8(1, Jan- June 2022): 3-12. doi:10.5455/jrtm.2022/125819



Vancouver/ICMJE Style

Gajare KV, Ukhalkar V, Podhade S, Pathak S, Vedula S, Rai RK, JLN S. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. J. res. tradit. med. (2022), [cited June 08, 2024]; 8(1, Jan- June 2022): 3-12. doi:10.5455/jrtm.2022/125819



Harvard Style

Gajare, K. V., Ukhalkar, . V., Podhade, . S., Pathak, . S., Vedula, . S., Rai, . R. K. & JLN, . S. (2022) Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. J. res. tradit. med, 8 (1, Jan- June 2022), 3-12. doi:10.5455/jrtm.2022/125819



Turabian Style

Gajare, Kamalakar Vasant, Vijay Ukhalkar, Suresh Podhade, Santosh Pathak, Sasibhushan Vedula, Rajiva Kumar Rai, and Sastry JLN. 2022. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE, 8 (1, Jan- June 2022), 3-12. doi:10.5455/jrtm.2022/125819



Chicago Style

Gajare, Kamalakar Vasant, Vijay Ukhalkar, Suresh Podhade, Santosh Pathak, Sasibhushan Vedula, Rajiva Kumar Rai, and Sastry JLN. "Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 8 (2022), 3-12. doi:10.5455/jrtm.2022/125819



MLA (The Modern Language Association) Style

Gajare, Kamalakar Vasant, Vijay Ukhalkar, Suresh Podhade, Santosh Pathak, Sasibhushan Vedula, Rajiva Kumar Rai, and Sastry JLN. "Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 8.1, Jan- June 2022 (2022), 3-12. Print. doi:10.5455/jrtm.2022/125819



APA (American Psychological Association) Style

Gajare, K. V., Ukhalkar, . V., Podhade, . S., Pathak, . S., Vedula, . S., Rai, . R. K. & JLN, . S. (2022) Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE, 8 (1, Jan- June 2022), 3-12. doi:10.5455/jrtm.2022/125819